Our results provide new insights into the molecular mechanisms underlying NSCLC metastasis and suggest that targeting the OCT4-DUSP6-Notch signaling axis may hold therapeutic potential. The gene discussed is DUSP6; the disease is non-small cell lung carcinoma.